IGF1 and breast cancer: Loddo et al. [27] found that PAPP‐A is epigenetically silenced in precursor lesions and invasive breast cancer, and that downregulation of PAPP‐A promotes the invasion of breast cancer cells by regulating mitotic progression via modulating IGF‐1.